印度阿萨姆邦轮状病毒疫苗覆盖率的促进因素和障碍--定性研究

IF 2.7 Q3 IMMUNOLOGY Vaccine: X Pub Date : 2024-03-19 DOI:10.1016/j.jvacx.2024.100479
Rashmi Mehra , Arindam Ray , Sabita Das , Biman Kusum Chowdhury , Seema Singh Koshal , Rhythm Hora , Amrita Kumari , Amanjot Kaur , Syed F. Quadri , Arup Deb Roy
{"title":"印度阿萨姆邦轮状病毒疫苗覆盖率的促进因素和障碍--定性研究","authors":"Rashmi Mehra ,&nbsp;Arindam Ray ,&nbsp;Sabita Das ,&nbsp;Biman Kusum Chowdhury ,&nbsp;Seema Singh Koshal ,&nbsp;Rhythm Hora ,&nbsp;Amrita Kumari ,&nbsp;Amanjot Kaur ,&nbsp;Syed F. Quadri ,&nbsp;Arup Deb Roy","doi":"10.1016/j.jvacx.2024.100479","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Estimates suggest that 78,000 children died due to rotavirus gastroenteritis annually between 2011 and 2013 in India. The north eastern state of Assam reported 38.4% pediatric diarrheal admissions testing positive for rotavirus. Rotavirus vaccine (RVV) was introduced in Assam in 2017 following which the National Family Health Survey-5 (NFHS-5) (2019) revealed low RVV coverage in Assam with wide variation between the districts. the current study was conceptualized and undertaken to capture the enablers and barriers to RVV coverage in Assam.</p></div><div><h3>Methods</h3><p>Qualitative study conducted in 5 randomly selected districts in Assam. Participants (key informants) were recruited by purposive sampling at each level of the health system including healthcare officials, service providers and caregivers based on availability. Thirty-five in-depth interviews (IDIs) and five focus group discussions (FGDs) were conducted. Interviews were tape recorded and transcribed. Data was coded and analyzed using the thematic framework approach.</p></div><div><h3>Results</h3><p>Findings from the qualitative data collection were collated and analyzed under 7 identified themes. Difficult terrain, limited service provider availability and no catch-up training for new recruits were some of the barriers to RVV coverage. In contrast, Information, Education &amp; Communication (IEC) in vernacular language, RVV safety profile, development partner support and adequate RVV supply were identified as some of the enablers of RVV coverage.</p></div><div><h3>Conclusion</h3><p>Few broad recommendations to overcome identified barriers include comprehensive inter-sectoral coordination, regular monitoring and frequent refresher training sessions. There is a need for a future study utilizing existing coverage data and larger sample size to triangulate the findings of this study.</p></div>","PeriodicalId":43021,"journal":{"name":"Vaccine: X","volume":"18 ","pages":"Article 100479"},"PeriodicalIF":2.7000,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590136224000524/pdfft?md5=cbb7a4751a6a7bca3b7f8e92f7db257c&pid=1-s2.0-S2590136224000524-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Enablers and barriers to rotavirus vaccine coverage in Assam, India- A qualitative study\",\"authors\":\"Rashmi Mehra ,&nbsp;Arindam Ray ,&nbsp;Sabita Das ,&nbsp;Biman Kusum Chowdhury ,&nbsp;Seema Singh Koshal ,&nbsp;Rhythm Hora ,&nbsp;Amrita Kumari ,&nbsp;Amanjot Kaur ,&nbsp;Syed F. Quadri ,&nbsp;Arup Deb Roy\",\"doi\":\"10.1016/j.jvacx.2024.100479\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Estimates suggest that 78,000 children died due to rotavirus gastroenteritis annually between 2011 and 2013 in India. The north eastern state of Assam reported 38.4% pediatric diarrheal admissions testing positive for rotavirus. Rotavirus vaccine (RVV) was introduced in Assam in 2017 following which the National Family Health Survey-5 (NFHS-5) (2019) revealed low RVV coverage in Assam with wide variation between the districts. the current study was conceptualized and undertaken to capture the enablers and barriers to RVV coverage in Assam.</p></div><div><h3>Methods</h3><p>Qualitative study conducted in 5 randomly selected districts in Assam. Participants (key informants) were recruited by purposive sampling at each level of the health system including healthcare officials, service providers and caregivers based on availability. Thirty-five in-depth interviews (IDIs) and five focus group discussions (FGDs) were conducted. Interviews were tape recorded and transcribed. Data was coded and analyzed using the thematic framework approach.</p></div><div><h3>Results</h3><p>Findings from the qualitative data collection were collated and analyzed under 7 identified themes. Difficult terrain, limited service provider availability and no catch-up training for new recruits were some of the barriers to RVV coverage. In contrast, Information, Education &amp; Communication (IEC) in vernacular language, RVV safety profile, development partner support and adequate RVV supply were identified as some of the enablers of RVV coverage.</p></div><div><h3>Conclusion</h3><p>Few broad recommendations to overcome identified barriers include comprehensive inter-sectoral coordination, regular monitoring and frequent refresher training sessions. There is a need for a future study utilizing existing coverage data and larger sample size to triangulate the findings of this study.</p></div>\",\"PeriodicalId\":43021,\"journal\":{\"name\":\"Vaccine: X\",\"volume\":\"18 \",\"pages\":\"Article 100479\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-03-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2590136224000524/pdfft?md5=cbb7a4751a6a7bca3b7f8e92f7db257c&pid=1-s2.0-S2590136224000524-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine: X\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590136224000524\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590136224000524","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景据估计,2011 年至 2013 年间,印度每年有 78,000 名儿童死于轮状病毒肠胃炎。东北部的阿萨姆邦报告称,38.4%的儿童腹泻入院时轮状病毒检测呈阳性。阿萨姆邦于 2017 年引入轮状病毒疫苗 (RVV),随后进行的第五次全国家庭健康调查 (NFHS-5)(2019 年)显示,阿萨姆邦的 RVV 覆盖率较低,各地区之间差异很大。参与者(关键信息提供者)通过有目的的抽样在卫生系统的各个层面招募,包括医疗保健官员、服务提供者和护理人员。共进行了 35 次深入访谈 (IDI) 和 5 次焦点小组讨论 (FGD)。对访谈进行了录音和誊写。采用主题框架法对数据进行了编码和分析。结果对定性数据收集的结果进行了整理,并按照 7 个确定的主题进行了分析。困难的地形、服务提供商有限的可用性以及没有为新招募人员提供补习培训,是阻碍登记和志愿服务覆盖范围的一些障碍。与此相反,以本地语言进行的信息、教育和宣传(IEC)、登记造册的安全简介、发展伙伴的支持和充足的登记造册供应被认为是登记造册覆盖率的一些促进因素。今后有必要利用现有的覆盖率数据和更大的样本量进行研究,以便对本研究的结果进行三角测量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Enablers and barriers to rotavirus vaccine coverage in Assam, India- A qualitative study

Background

Estimates suggest that 78,000 children died due to rotavirus gastroenteritis annually between 2011 and 2013 in India. The north eastern state of Assam reported 38.4% pediatric diarrheal admissions testing positive for rotavirus. Rotavirus vaccine (RVV) was introduced in Assam in 2017 following which the National Family Health Survey-5 (NFHS-5) (2019) revealed low RVV coverage in Assam with wide variation between the districts. the current study was conceptualized and undertaken to capture the enablers and barriers to RVV coverage in Assam.

Methods

Qualitative study conducted in 5 randomly selected districts in Assam. Participants (key informants) were recruited by purposive sampling at each level of the health system including healthcare officials, service providers and caregivers based on availability. Thirty-five in-depth interviews (IDIs) and five focus group discussions (FGDs) were conducted. Interviews were tape recorded and transcribed. Data was coded and analyzed using the thematic framework approach.

Results

Findings from the qualitative data collection were collated and analyzed under 7 identified themes. Difficult terrain, limited service provider availability and no catch-up training for new recruits were some of the barriers to RVV coverage. In contrast, Information, Education & Communication (IEC) in vernacular language, RVV safety profile, development partner support and adequate RVV supply were identified as some of the enablers of RVV coverage.

Conclusion

Few broad recommendations to overcome identified barriers include comprehensive inter-sectoral coordination, regular monitoring and frequent refresher training sessions. There is a need for a future study utilizing existing coverage data and larger sample size to triangulate the findings of this study.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vaccine: X
Vaccine: X Multiple-
CiteScore
2.80
自引率
2.60%
发文量
102
审稿时长
13 weeks
期刊最新文献
Immunogenicities of vaccines including the immunoglobulin M-degrading enzyme of Streptococcus suis, rIdeSsuis, and protective efficacy against serotype 14 in piglets The importance of quality of health campaign information for outcome evaluation. A case study from Guinea-Bissau and Bangladesh Mumps outbreak in Zimbabwe: The case for universal MMR vaccination in Africa The clinical and economic value of enhanced influenza vaccines for the elderly in Argentina Cost of the typhoid conjugate vaccine introduction through an integrated campaign and follow-on routine immunization in Malawi
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1